Commit Biologics secured €16 million in a seed funding led by Bioqube Ventures and Novo Holdings to accelerate the development of their immune system activation technology for cancer and autoimmune disease treatment.
Amount Raised
€16 Million
Round Type
Seed
AarhusBiotechnologyHealth CareTherapeuticsInvestors
Description
Commit Biologics, based in Aarhus, has secured €16 million in seed funding led by Bioqube Ventures and Novo Holdings. The company specializes in activating the complement system, a part of the immune system, to treat cancer and autoimmune diseases. The funding will be used to accelerate the development of their unique Bispecific Complement Engaging (BiCE™) platform, potentially revolutionizing cancer and autoimmune disease treatment.
Quick answer
Commit Biologics raised €16 Million in a Seed round, dated May 10, 2024. Investors: Novo Holdings and Bioqube Ventures. Commit Biologics is based in Aarhus, Central Denmark Region, Denmark.
- How much did Commit Biologics raise?
- Commit Biologics raised €16 Million in a Seed round on May 10, 2024.
- Who invested in Commit Biologics?
- Novo Holdings and Bioqube Ventures are named as investors in this round.
- What does Commit Biologics do?
- Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.
- Where is Commit Biologics based and how big is it?
- Commit Biologics is based in Aarhus, Central Denmark Region, Denmark. Fundz records about 20 employees.
- Who are the decision-makers at Commit Biologics?
- Fundz holds 1 contact at Commit Biologics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Commit Biologics that raised within 45 days of this round, from Fundz verified event records.
- Cypris Therapeutics raised $500K (Pre-Seed) on June 24, 2024.
- EpilepsyGTx raised $10M (Seed) on June 24, 2024.
- OCON Therapeutics raised $10M (Funding Round) on June 24, 2024.
- āshibio raised $40M (Series A) on June 20, 2024.
- iOnctura BV raised $86M (Series B) on June 20, 2024.
- Autobahn Therapeutics raised $101M on June 20, 2024.
Who to call at Commit Biologics, and when
A new round usually means Commit Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Commit Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Commit Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Commit Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Commit Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Commit Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.